Integral Health Asset Management, LLC

Position in ALKS — Alkermes plc.

CIK 1773206 New York, NY

Back to ALKS Full portfolio

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,240,000

+$2,379,000 QoQ

Shares Held

100,000

0.0% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#122

of 423 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Integral Health Asset Management, LLC holds $58,952,600 across 4 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	150,000	$25,281,000
2	LNTH	Lantheus Holdings, Inc.	190,000	$21,078,600
3	BIOA	BioAge Labs, Inc.	300,000	$7,353,000
4	ALKS	Alkermes plc. This page	100,000	$5,240,000

All Filings in ALKS

Export CSV

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,240,000	100,000	0.0%	Shares	Sole	2026-08-14
2025-06-30	$2,861,000	100,000	-33.3%	Shares	Sole	2025-08-14
2025-03-31	$4,953,000	150,000	-40.0%	Shares	Sole	2025-05-15
2024-03-31	$6,767,500	250,000	+0.4%	Shares	Sole	2024-05-15
2023-12-31	$6,907,260	249,000	-9.5%	Shares	Sole	2024-02-14
2023-09-30	$7,702,750	275,000	-3.2%	Shares	Sole	2023-11-14
2023-06-30	$8,889,200	284,000	+58.7%	Shares	Sole	2023-08-11
2023-03-31	$5,046,010	179,000	-10.5%	Shares	Sole	2023-05-09
2022-09-30	$4,466,000	200,000	-23.7%	Shares	Sole	2022-11-14
2022-06-30	$7,803,967	261,966	+4.8%	Shares	Sole	2022-08-03
2022-03-31	$6,577,500	250,000	+400.0%	Shares	Sole	2022-05-12
2021-12-31	$1,163,000	50,000	-66.7%	Shares	Sole	2022-02-02
2021-06-30	$3,678,000	150,000	0.0%	Shares	Sole	2021-08-30
2020-03-31	$2,163,000	150,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.